Dr. Janice Maynor
speaker
10 appearances
1 recordings
1 series
first heard Jun 2026
last heard 1 Jun
Dr. Janice Maynor’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in Jun 2026 with 1.
Appearances
Scientists used mRNA technology to create a personalized immunotherapy for melanoma patients.
who are at high risk of having the cancer come back and spread.
Dr. Janice Maynor of NYU is one of the authors of the new study.
After five years of follow-up, 68.8% of patients who took the combination therapy remained cancer-free.
In addition, 92% of patients who received the personalized immunotherapy were still alive at the five-year mark.
a significant reduction in the risk of dying from melanoma.
Each year, about 112,000 melanomas are diagnosed in the U.S.
It can also spread to organs including the brain and lungs.
Melanoma experts say this is a landmark advance in how high-risk melanomas could be treated.
Allison Aubrey, NPR News.
Showing 1–10 of 10